ArticleJournal of chemical information and modeling2026
LINKER:
Article in Journal of chemical information and modeling, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- KANPM-DTA: improving drug-target affinity prediction with Kolmogorov-Arnold networks and pretrained models.Briefings in bioinformatics · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Accurate identification of interactions between protein residues and ligand functional groups is critical for understanding molecular recognition and guiding rational drug design. Existing deep learning approaches for protein-ligand interpretability typically rely on three-dimensional structural input or distance-based contact labels, which limit both their applicability and biological relevance. Here, we present LINKER, the first sequence-based model to predict residue-functional group interactions according to biologically defined interaction types, using only a protein sequence and the SMILES representation of the ligand. LINKER is trained via structure-supervised interaction learning, in which interaction labels are derived from three-dimensional protein-ligand complexes through functional group-based motif extraction. By representing ligands as ensembles of functional groups, the model emphasizes chemically meaningful substructures rather than mere spatial proximity. Importantly, LINKER requires only sequence-level input at inference, enabling large-scale applications in contexts where structural data are unavailable. Extensive experiments demonstrate that LINKER consistently outperforms established baselines, highlighting the utility of functional group abstractions and structure-based supervision for interpretable protein-ligand interaction prediction. Our source code is publicly available at: https://github.com/HySonLab/LINKER/.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.